nodes	percent_of_prediction	percent_of_DWPC	metapath
Olsalazine—PTGS2—amyotrophic lateral sclerosis	0.732	1	CbGaD
Olsalazine—IFNG—Hypertrophy Model—MSTN—amyotrophic lateral sclerosis	0.0224	0.137	CbGpPWpGaD
Olsalazine—PPARG—forelimb—amyotrophic lateral sclerosis	0.0122	0.126	CbGeAlD
Olsalazine—PPARG—hindlimb—amyotrophic lateral sclerosis	0.011	0.114	CbGeAlD
Olsalazine—PPARG—appendage—amyotrophic lateral sclerosis	0.00944	0.0976	CbGeAlD
Olsalazine—IFNG—Senescence and Autophagy in Cancer—GABARAPL2—amyotrophic lateral sclerosis	0.00785	0.048	CbGpPWpGaD
Olsalazine—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.00562	0.0581	CbGeAlD
Olsalazine—IFNG—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.00542	0.0331	CbGpPWpGaD
Olsalazine—PTGS2—appendage—amyotrophic lateral sclerosis	0.00482	0.0499	CbGeAlD
Olsalazine—IFNG—spinal cord—amyotrophic lateral sclerosis	0.00468	0.0484	CbGeAlD
Olsalazine—IFNG—nervous system—amyotrophic lateral sclerosis	0.00395	0.0408	CbGeAlD
Olsalazine—IFNG—central nervous system—amyotrophic lateral sclerosis	0.0038	0.0393	CbGeAlD
Olsalazine—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.00373	0.0228	CbGpPWpGaD
Olsalazine—PPARG—embryo—amyotrophic lateral sclerosis	0.00313	0.0324	CbGeAlD
Olsalazine—TPMT—medulla oblongata—amyotrophic lateral sclerosis	0.00303	0.0313	CbGeAlD
Olsalazine—IFNG—brain—amyotrophic lateral sclerosis	0.00302	0.0312	CbGeAlD
Olsalazine—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00301	0.0184	CbGpPWpGaD
Olsalazine—PPARG—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00275	0.0168	CbGpPWpGaD
Olsalazine—TPMT—spinal cord—amyotrophic lateral sclerosis	0.0027	0.0279	CbGeAlD
Olsalazine—IFNG—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00262	0.016	CbGpPWpGaD
Olsalazine—IFNG—Calcium signaling in the CD4+ TCR pathway—CD40LG—amyotrophic lateral sclerosis	0.00259	0.0158	CbGpPWpGaD
Olsalazine—IFNG—Inflammatory Response Pathway—CD40LG—amyotrophic lateral sclerosis	0.00252	0.0154	CbGpPWpGaD
Olsalazine—TPMT—nervous system—amyotrophic lateral sclerosis	0.00227	0.0235	CbGeAlD
Olsalazine—TPMT—central nervous system—amyotrophic lateral sclerosis	0.00219	0.0226	CbGeAlD
Olsalazine—ALOX5—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00219	0.0134	CbGpPWpGaD
Olsalazine—PPARG—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00218	0.0133	CbGpPWpGaD
Olsalazine—TPMT—cerebellum—amyotrophic lateral sclerosis	0.00214	0.0221	CbGeAlD
Olsalazine—IFNG—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.00211	0.0129	CbGpPWpGaD
Olsalazine—ALOX5—nervous system—amyotrophic lateral sclerosis	0.002	0.0207	CbGeAlD
Olsalazine—TPMT—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00193	0.0118	CbGpPWpGaD
Olsalazine—ALOX5—central nervous system—amyotrophic lateral sclerosis	0.00193	0.0199	CbGeAlD
Olsalazine—ALOX5—cerebellum—amyotrophic lateral sclerosis	0.00189	0.0195	CbGeAlD
Olsalazine—IFNG—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.00184	0.0112	CbGpPWpGaD
Olsalazine—PPARG—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00183	0.0112	CbGpPWpGaD
Olsalazine—TPMT—brain—amyotrophic lateral sclerosis	0.00174	0.018	CbGeAlD
Olsalazine—IFNG—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.00172	0.0105	CbGpPWpGaD
Olsalazine—IFNG—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.0017	0.0104	CbGpPWpGaD
Olsalazine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.00167	0.0102	CbGpPWpGaD
Olsalazine—PTGS2—embryo—amyotrophic lateral sclerosis	0.0016	0.0166	CbGeAlD
Olsalazine—Balsalazide—PTGS2—amyotrophic lateral sclerosis	0.00156	0.218	CrCbGaD
Olsalazine—IFNG—SHP2 signaling—BDNF—amyotrophic lateral sclerosis	0.00156	0.00951	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.00155	0.0095	CbGpPWpGaD
Olsalazine—IFNG—Hypertrophy Model—VEGFA—amyotrophic lateral sclerosis	0.00155	0.00945	CbGpPWpGaD
Olsalazine—ALOX5—brain—amyotrophic lateral sclerosis	0.00153	0.0158	CbGeAlD
Olsalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—RAB5A—amyotrophic lateral sclerosis	0.00152	0.0093	CbGpPWpGaD
Olsalazine—PPARG—nervous system—amyotrophic lateral sclerosis	0.0015	0.0156	CbGeAlD
Olsalazine—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.0015	0.00919	CbGpPWpGaD
Olsalazine—IFNG—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.00149	0.00913	CbGpPWpGaD
Olsalazine—IFNG—IL1 and megakaryotyces in obesity—MMP9—amyotrophic lateral sclerosis	0.00149	0.0091	CbGpPWpGaD
Olsalazine—IFNG—Senescence and Autophagy in Cancer—IGFBP3—amyotrophic lateral sclerosis	0.00149	0.00909	CbGpPWpGaD
Olsalazine—TPMT—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.00148	0.00902	CbGpPWpGaD
Olsalazine—IFNG—Calcium signaling in the CD4+ TCR pathway—PTGS2—amyotrophic lateral sclerosis	0.00146	0.00891	CbGpPWpGaD
Olsalazine—PPARG—central nervous system—amyotrophic lateral sclerosis	0.00145	0.015	CbGeAlD
Olsalazine—IFNG—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.00144	0.00881	CbGpPWpGaD
Olsalazine—ALOX5—Eicosanoid Synthesis—PTGS2—amyotrophic lateral sclerosis	0.00141	0.00865	CbGpPWpGaD
Olsalazine—ALOX5—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00139	0.00853	CbGpPWpGaD
Olsalazine—IFNG—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.00136	0.00828	CbGpPWpGaD
Olsalazine—Magnesium salicylate—PTGS2—amyotrophic lateral sclerosis	0.00133	0.185	CrCbGaD
Olsalazine—IFNG—Senescence and Autophagy in Cancer—SQSTM1—amyotrophic lateral sclerosis	0.00129	0.00786	CbGpPWpGaD
Olsalazine—Diflunisal—PTGS2—amyotrophic lateral sclerosis	0.00125	0.174	CrCbGaD
Olsalazine—IFNG—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.00119	0.00725	CbGpPWpGaD
Olsalazine—IFNG—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.00116	0.00709	CbGpPWpGaD
Olsalazine—PPARG—brain—amyotrophic lateral sclerosis	0.00115	0.0119	CbGeAlD
Olsalazine—Salsalate—PTGS2—amyotrophic lateral sclerosis	0.00113	0.158	CrCbGaD
Olsalazine—PPARG—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.00103	0.00629	CbGpPWpGaD
Olsalazine—IFNG—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.00103	0.00627	CbGpPWpGaD
Olsalazine—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.00102	0.0106	CbGeAlD
Olsalazine—IFNG—SHP2 signaling—IGF1—amyotrophic lateral sclerosis	0.00101	0.00617	CbGpPWpGaD
Olsalazine—ALOX5—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000989	0.00605	CbGpPWpGaD
Olsalazine—Mesalazine—PTGS2—amyotrophic lateral sclerosis	0.000982	0.137	CrCbGaD
Olsalazine—ALOX5—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000972	0.00594	CbGpPWpGaD
Olsalazine—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.000954	0.00987	CbGeAlD
Olsalazine—PTGS1—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000949	0.0058	CbGpPWpGaD
Olsalazine—PPARG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000945	0.00577	CbGpPWpGaD
Olsalazine—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—amyotrophic lateral sclerosis	0.000944	0.00577	CbGpPWpGaD
Olsalazine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	0.000943	0.00577	CbGpPWpGaD
Olsalazine—Sulfasalazine—PTGS2—amyotrophic lateral sclerosis	0.000922	0.128	CrCbGaD
Olsalazine—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000912	0.00943	CbGeAlD
Olsalazine—PTGS1—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.00091	0.00556	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000889	0.00543	CbGpPWpGaD
Olsalazine—IFNG—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000882	0.00539	CbGpPWpGaD
Olsalazine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000876	0.00535	CbGpPWpGaD
Olsalazine—TPMT—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000864	0.00528	CbGpPWpGaD
Olsalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.000863	0.00528	CbGpPWpGaD
Olsalazine—TPMT—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000852	0.00521	CbGpPWpGaD
Olsalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—amyotrophic lateral sclerosis	0.000833	0.00509	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000827	0.00505	CbGpPWpGaD
Olsalazine—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000804	0.00832	CbGeAlD
Olsalazine—ALOX5—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000786	0.00481	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000777	0.00475	CbGpPWpGaD
Olsalazine—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000774	0.00801	CbGeAlD
Olsalazine—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000769	0.00795	CbGeAlD
Olsalazine—PTGS2—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000753	0.0046	CbGpPWpGaD
Olsalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—amyotrophic lateral sclerosis	0.000742	0.00454	CbGpPWpGaD
Olsalazine—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.00074	0.00765	CbGeAlD
Olsalazine—PTGS1—Overview of nanoparticle effects—PTGS2—amyotrophic lateral sclerosis	0.000739	0.00452	CbGpPWpGaD
Olsalazine—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000723	0.00748	CbGeAlD
Olsalazine—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.000723	0.00442	CbGpPWpGaD
Olsalazine—PPARG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000716	0.00437	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000662	0.00404	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000662	0.00404	CbGpPWpGaD
Olsalazine—IFNG—SHP2 signaling—VEGFA—amyotrophic lateral sclerosis	0.00066	0.00403	CbGpPWpGaD
Olsalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	0.000639	0.0039	CbGpPWpGaD
Olsalazine—IFNG—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	0.000632	0.00386	CbGpPWpGaD
Olsalazine—IFNG—Senescence and Autophagy in Cancer—IGF1—amyotrophic lateral sclerosis	0.000628	0.00384	CbGpPWpGaD
Olsalazine—PTGS1—brain—amyotrophic lateral sclerosis	0.000615	0.00636	CbGeAlD
Olsalazine—PTGS1—Eicosanoid Synthesis—PTGS2—amyotrophic lateral sclerosis	0.000613	0.00375	CbGpPWpGaD
Olsalazine—IFNG—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000607	0.00371	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.000607	0.00371	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000605	0.0037	CbGpPWpGaD
Olsalazine—PTGS1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000605	0.0037	CbGpPWpGaD
Olsalazine—PPARG—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000602	0.00368	CbGpPWpGaD
Olsalazine—IFNG—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.0006	0.00367	CbGpPWpGaD
Olsalazine—PTGS2—brain—amyotrophic lateral sclerosis	0.000588	0.00608	CbGeAlD
Olsalazine—IFNG—Cytokine Signaling in Immune system—SQSTM1—amyotrophic lateral sclerosis	0.000587	0.00359	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000563	0.00344	CbGpPWpGaD
Olsalazine—PPARG—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00055	0.00336	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000533	0.00326	CbGpPWpGaD
Olsalazine—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	0.000531	0.00324	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000529	0.00323	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000516	0.00316	CbGpPWpGaD
Olsalazine—IFNG—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000515	0.00315	CbGpPWpGaD
Olsalazine—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.000513	0.00314	CbGpPWpGaD
Olsalazine—PPARG—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000512	0.00313	CbGpPWpGaD
Olsalazine—IFNG—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000509	0.00311	CbGpPWpGaD
Olsalazine—ALOX5—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.0005	0.00306	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000495	0.00302	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000489	0.00299	CbGpPWpGaD
Olsalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	0.000487	0.00298	CbGpPWpGaD
Olsalazine—PPARG—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000485	0.00296	CbGpPWpGaD
Olsalazine—PPARG—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000481	0.00294	CbGpPWpGaD
Olsalazine—PTGS2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00048	0.00293	CbGpPWpGaD
Olsalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.00048	0.00293	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—DAO—amyotrophic lateral sclerosis	0.000478	0.00292	CbGpPWpGaD
Olsalazine—IFNG—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000475	0.0029	CbGpPWpGaD
Olsalazine—PTGS2—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	0.000462	0.00283	CbGpPWpGaD
Olsalazine—PPARG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000455	0.00278	CbGpPWpGaD
Olsalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000452	0.00276	CbGpPWpGaD
Olsalazine—IFNG—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.00045	0.00275	CbGpPWpGaD
Olsalazine—IFNG—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000441	0.00269	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000433	0.00265	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000433	0.00265	CbGpPWpGaD
Olsalazine—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000429	0.00262	CbGpPWpGaD
Olsalazine—IFNG—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	0.000429	0.00262	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000422	0.00258	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000421	0.00257	CbGpPWpGaD
Olsalazine—IFNG—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000416	0.00254	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000404	0.00247	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000396	0.00242	CbGpPWpGaD
Olsalazine—PPARG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000387	0.00236	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000386	0.00236	CbGpPWpGaD
Olsalazine—IFNG—Glucocorticoid receptor regulatory network—TP53—amyotrophic lateral sclerosis	0.000378	0.00231	CbGpPWpGaD
Olsalazine—PPARG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000376	0.0023	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000368	0.00225	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000363	0.00222	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000358	0.00219	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000346	0.00212	CbGpPWpGaD
Olsalazine—PPARG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000345	0.00211	CbGpPWpGaD
Olsalazine—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000341	0.00208	CbGpPWpGaD
Olsalazine—PTGS2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000341	0.00208	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000337	0.00206	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—GSR—amyotrophic lateral sclerosis	0.000335	0.00205	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000335	0.00205	CbGpPWpGaD
Olsalazine—PPARG—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00033	0.00202	CbGpPWpGaD
Olsalazine—PPARG—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000319	0.00195	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—DAO—amyotrophic lateral sclerosis	0.000313	0.00191	CbGpPWpGaD
Olsalazine—IFNG—Senescence and Autophagy in Cancer—TP53—amyotrophic lateral sclerosis	0.00031	0.0019	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000306	0.00187	CbGpPWpGaD
Olsalazine—IFNG—Immune System—DCTN1—amyotrophic lateral sclerosis	0.0003	0.00183	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000289	0.00177	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000285	0.00174	CbGpPWpGaD
Olsalazine—IFNG—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000282	0.00173	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000281	0.00172	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000275	0.00168	CbGpPWpGaD
Olsalazine—PPARG—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000273	0.00167	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000268	0.00164	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000268	0.00164	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000268	0.00164	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000264	0.00162	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000253	0.00155	CbGpPWpGaD
Olsalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000251	0.00154	CbGpPWpGaD
Olsalazine—PPARG—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00025	0.00153	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000245	0.0015	CbGpPWpGaD
Olsalazine—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000245	0.0015	CbGpPWpGaD
Olsalazine—PPARG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000239	0.00146	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000237	0.00145	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000231	0.00141	CbGpPWpGaD
Olsalazine—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000228	0.00139	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000228	0.00139	CbGpPWpGaD
Olsalazine—PPARG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000222	0.00136	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000219	0.00134	CbGpPWpGaD
Olsalazine—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000217	0.00133	CbGpPWpGaD
Olsalazine—PPARG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000215	0.00131	CbGpPWpGaD
Olsalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.000214	0.00131	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000214	0.00131	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000204	0.00125	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000199	0.00122	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—DAO—amyotrophic lateral sclerosis	0.000194	0.00118	CbGpPWpGaD
Olsalazine—IFNG—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000192	0.00117	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000188	0.00115	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000188	0.00115	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000183	0.00112	CbGpPWpGaD
Olsalazine—PPARG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000181	0.00111	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00018	0.0011	CbGpPWpGaD
Olsalazine—IFNG—Immune System—ATF1—amyotrophic lateral sclerosis	0.00018	0.0011	CbGpPWpGaD
Olsalazine—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	0.000178	0.00109	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000175	0.00107	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000172	0.00105	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000172	0.00105	CbGpPWpGaD
Olsalazine—IFNG—Immune System—CASP9—amyotrophic lateral sclerosis	0.000171	0.00105	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000164	0.001	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000164	0.001	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00016	0.000976	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00015	0.000917	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000149	0.000911	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000149	0.000911	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000148	0.000903	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000147	0.000897	CbGpPWpGaD
Olsalazine—IFNG—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000146	0.000895	CbGpPWpGaD
Olsalazine—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	0.000142	0.000869	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000139	0.000849	CbGpPWpGaD
Olsalazine—IFNG—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000138	0.000842	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000136	0.000833	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000136	0.00083	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000136	0.00083	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—GSR—amyotrophic lateral sclerosis	0.000136	0.000828	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000127	0.000774	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000126	0.000773	CbGpPWpGaD
Olsalazine—PPARG—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000123	0.000754	CbGpPWpGaD
Olsalazine—IFNG—Immune System—C3—amyotrophic lateral sclerosis	0.000122	0.000744	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000119	0.00073	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000119	0.000728	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000112	0.000687	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000112	0.000683	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—APOE—amyotrophic lateral sclerosis	0.000112	0.000682	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000111	0.00068	CbGpPWpGaD
Olsalazine—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000108	0.000659	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000108	0.000659	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000103	0.000629	CbGpPWpGaD
Olsalazine—PPARG—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000102	0.000621	CbGpPWpGaD
Olsalazine—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	9.75e-05	0.000596	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.66e-05	0.000591	CbGpPWpGaD
Olsalazine—PPARG—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	9.52e-05	0.000582	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	9.49e-05	0.00058	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.88e-05	0.000543	CbGpPWpGaD
Olsalazine—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	8.69e-05	0.000531	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.64e-05	0.000528	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	8.6e-05	0.000526	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	8.17e-05	0.000499	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	8.11e-05	0.000495	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.8e-05	0.000476	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.65e-05	0.000468	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	7.54e-05	0.000461	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—APOE—amyotrophic lateral sclerosis	7.31e-05	0.000446	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.3e-05	0.000446	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.11e-05	0.000435	CbGpPWpGaD
Olsalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.96e-05	0.000425	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.86e-05	0.000419	CbGpPWpGaD
Olsalazine—PPARG—Developmental Biology—MMP9—amyotrophic lateral sclerosis	6.83e-05	0.000418	CbGpPWpGaD
Olsalazine—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	6.24e-05	0.000381	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.19e-05	0.000378	CbGpPWpGaD
Olsalazine—PPARG—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	6.14e-05	0.000375	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.98e-05	0.000366	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.65e-05	0.000345	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.51e-05	0.000337	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.5e-05	0.000336	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.01e-05	0.000306	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.87e-05	0.000298	CbGpPWpGaD
Olsalazine—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	4.53e-05	0.000277	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—APOE—amyotrophic lateral sclerosis	4.52e-05	0.000276	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.19e-05	0.000256	CbGpPWpGaD
Olsalazine—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	3.88e-05	0.000237	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.85e-05	0.000235	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.33e-05	0.000203	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	3.17e-05	0.000194	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.1e-05	0.000189	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.06e-05	0.000187	CbGpPWpGaD
Olsalazine—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	3e-05	0.000184	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	2.51e-05	0.000154	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.17e-05	0.000133	CbGpPWpGaD
